Fusion Pharmaceuticals (NASDAQ:FUSN) reported quarterly losses of $(0.42) per share. This is a 93.01 percent increase over losses of $(6.01) per share from the same period last year.
Mobile Operators Collaborate To Deploy Open Network APIs To Win Cloud Developers
The GSMA representing the biggest mobile phone operators, shared plans to launch a new united interface providing developers…